• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

21.39 USD 0.36 1.71%

As of 09:29:30 ET on 10/23/2014.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +17.72% 3-Month: +1.95% 3-Year: +26.37% 52-Week Range: 16.99 - 21.90
1-Month: -0.65% 1-Year: +28.15% 5-Year: +22.34% Beta vs MXWO: 0.90

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 21.39
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2014-10-23) 21.39
Assets (M) (on 2014-09-30) 1,583.24
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-04-11) 0.35
Dividend Yield (ttm) 12.80

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.81

Top Fund Holdings for FPHAX

Filing Date: 08/31/2014
Name Position Value % of Total
Actavis plc 594,907 135,031,991 8.769%
AbbVie Inc 2,024,190 111,897,223 7.266%
AstraZeneca PLC 1,079,100 82,022,391 5.326%
Novartis AG 875,298 78,636,772 5.106%
Bristol-Myers Squibb Co 1,517,210 76,846,687 4.990%
Johnson & Johnson 725,700 75,276,861 4.888%
Shire PLC 271,500 66,341,025 4.308%
Merck & Co Inc 1,102,336 66,261,417 4.303%
Perrigo Co PLC 405,252 60,277,182 3.914%
Valeant Pharmaceuticals Intern 455,127 53,319,302 3.462%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil